UV induced skin immunosuppression

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 8, Issue 1, 2009, Pages 3-13

  Amerio, Paolo ^a   Carbone, Angelo ^a   Auriemma, Matteo ^a   Varrati, Stefano ^a   Tulli, Antonello ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Immunology; Immunosuppression; Skin; Ultraviolet light; UV

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD11 ANTIGEN; DNA; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; NERVE GROWTH FACTOR; PROSTAGLANDIN E2; PYRIMIDINE DIMER; SEROTONIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ANTIGEN PRESENTING CELL; CELL DAMAGE; CELL MIGRATION; CYTOKINE PRODUCTION; DNA DAMAGE; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; LANGERHANS CELL; NONHUMAN; PHOTORECEPTOR; RADIATION CARCINOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; SKIN CANCER; SKIN INFECTION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

EID: 67651121994     PISSN: 18715230     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152309787580775     Document Type: Review

References (151)

1. Yeatman, J.; Marks, R. Non melanoma skin cancer. Med. J. Austral., 1996, 164, 492-496.
2. Goldberg, L.H. Basal cell carcinoma. Lancet, 1996, 347, 663-667.
3. Lens, M.B.; Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br. J. Dermatol., 2004, 150, 179-185.
4. Rigel, D.S. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J. Am. Acad. Dermatol., 2008, 58, S129-32.
5. Slaper, H.; Velders, G.J.; Daniel, J.S.; De Gruijl, F.R.; Van Der Leun, F. Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature, 1996, 384, 256-258.
6. Diffey, B. Climate change, ozone depletion and the impact on ultraviolet exposure of human skin. Phys. Med. Biol., 2004, 49 (1), R1-11.
7. Muller, H.K.; Malley, R.C.; McGee, H.M.; Scott, D.K.; Wozniak, T.; Woods, G.M. Effect of UV radiation on the neonatal skin immune system- implications for melanoma. Photochem. Photobiol., 2008, 84 (1), 47-54.
8. Rünger, T.M. How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis, the role of cellular damage responses. J. Invest. Dermatol., 2007, 127 (9), 2103-2105.
9. LeVee, G.J.; Oberhalman, L.; Anderson, T.; Koren, H.; Cooper, K.D. UVA 2 exposure of human skin results in increased immunization capacities increased induction of tolerance and a unique pattern of epidermal antigen presenting cell alteration. Photochem. Photobiol., 1997, 65, 622-629.
10. Morita, A.; Grewe, M.; Greter, Beck S.; Olaizola, H.; Horn, S.; Krutmann, H. Induction of inflammatory cytokynes in human epidermoid carcinoma cell lines in vitro by Ultraviolet A I irradiation. Photochem. Photobiol., 1997, 65, 630-635.
11. Fichtelius, K.E.; Groth, O.; Liden, S. The skin, a first level lymphoid organ? Int. Arch. Allergy Appl. Immunol., 1970, 37 (6), 607-620.
12. Streinein, J.W. Lymphocyte traffic T-cell malignancies and the skin. J. Invest. Dermatol., 1978, 71, 167-171.
13. Bos, J.D.; Zonneveld, I.; Das, P.K.; Krieg, S.R.; van der Loos, C.M.; Kapsenberg, M.L. The skin immune system (SIS), distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J. Invest. Dermatol., 1987, 88 (5), 569-573.
14. Burnet, F.M. Immunological Surveillance. Pergamon Press, Oxford, 1970.
15. Meyer, T.; Stockfleth, E.; Christophers, E. Immune response profiles in human skin. Br. J. Dermatol., 2007, 157 (Suppl. 2), 1-7.
16. Fisher, M.S.; Kripkie, M.L. Suppressor T lymphocytes control the development of primary skin cancer in UV irradiated mice. Science, 1982, 216, 1133-1134.
17. Bruls, W.A.G.; Slaper, H.; Van der Leun, J.C.; Berrens, L. Transmission of human epidermidis and stratum coneum as a function of thickness in the ultraviolet and visible wavelength. Photochem. Photobiol., 1984, 40, 485-494.
18. Ziegler, A.; Johnason, S.; Leffel, D.J.; Simon, J.A.; Sharma, H.W.; Kimmelmen, J.; Remington, L.; Jacks, T.; Brash D.E. Sunburn and p53 in the onset of skin cancer. Nature, 1994, 372, 773-776.
19. D'Errico, M.; Calcagnile, A.S.; Corona, R.; Fucci, M.; Annessi, G.; Baliva, G.; Tosti, M.E.; Pasquini, P.; Dogliotti, E. p53 mutations and chromosome instability in Basal cel carcinomas development at early or late stage. Cancer Res., 1997, 57, 747-752.
20. Grewe, M.; Gyufko, K.; Budnik, A.; Ruzicka, T.; Olaizola-Horn, S.; Berneburg, M.; Krutmann, J. Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation. J. Invest. Dermatol., 1996, 107(6), 865-870.
21. Rundhaug, J.E.; Mikulec, C.; Pavone, A.; Fischer, S.M. A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis. Mol. Carcinog., 2007, 46(8), 692-698.
22. Devary, Y.; Goettlieb, R.A.; Sameal, T.; Karin, M. The mammalian ultraviolet response is triggered by activation of src Tyrosinase kinases. Cell, 1992, 71, 108-191.
23. Cooper, S.J.; Bowden, G.T. Ultraviolet B regulation of transcription factor families, roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr. Cancer Drug Targets, 2007, 7(4), 325-34.
24. Aragane, Y.; Schwarz, A.; Luger, T.A.; Ariizumi, K.; Takashima, A.; Schwarz, T. Ultraviolet light suppresses IFNgamma induced IL-7 gene expression in murine keratinocytes by interfering with INF regulatory factors. J. Immunol., 1997, 1578, 5393-5399.
25. van der Broeke, L.T.; Beijersgergen van Henegouwen, G.M. Topically applied N-acetylcysteine as a protector against UVB-induced systemic immunosuppression. J. Photochem. Photobiol. B., 1995, 27 (1), 61-65.
26. Katiyar, S.K.; Meleth, S.; Sharma, S.D. Silymarin, a flavonoid from milk thistle (Silybum marianum L.), inhibits UV-induced oxidative stress through targeting infiltrating CD11b+ cells in mouse skin. Photochem. Photobiol., 2008, 84(2), 266-271.
27. Kripkie, M.L. Ultraviolet radiation and Immunology, something new under the sun- presidential address. Cancer Res., 1994, 54, 6102-6105.
28. Kripkie, M.L. Antigenicty of murine skin tumors induced by ultraviolet light. J. Natl.Cancer Inst., 1974, 53, 1333-1336.
29. Elmets, C.A.; Bergstresser, P.R.; Tigelaar, R.E.; Wood, P.J.; Streilein, J.W. Analysis of the mechanism of unresponsivensess produced by haptens paintedon skin expopsed to low dose ultraviolet radiation. J. Exp. Med., 1983, 158, 781.
30. Toews, G.B.; Bergstresser, P.R.; Streilein, J.W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol., 1980, 124(1), 445-453.
31. Kripke, M.L. Immunological unresponsiveness induced by ultraviolet radiation. Immunol. Rev., 1984, 80, 84.
32. Shimizu, T.; Streilein, J.W. Local and systemic consequences of acute low dose ultraviolet be radiation are mediated by different immune regulatory mechanisms. Eur. J. Immunol., 1994, 24, 1765-1770.
33. Yoshikawa, T.; Rae, V.; Briuns-Slot, W.; van de Berg, J.W.; Taylor, R.; treinlein, J.W. Susceptibility to effects of UVB radiation on induction of CHS as a risck factor for skin cancer in men. J. Invest. Dermatol., 1990, 95, 530-536.
34. Streilein, J.W. Sunlight and skin associated lymphoid tissue (SALT), if UVB is the trigger and TNF-α itsmediator, what is the message? J. Invest. Dermatol., 1993, 100, 47s-52s.
35. Golomb, C.; Tie, C.; Kurimoto, I.; Taylor, J.R.; Streilein, J.W. Funtional evidence that the UVB-S and UVB-R phenotipic traits in man are genetically determined. J. Invest. Dermatol., 1993, 100, 601.
36. Vincek, V.; Kurimoto, I.; Medema, J.P.; Prieto, E.; Streilein, J.W. TNF alpha polymorphism correlates deleteriouis effects of ultraviolet B light effects on cutaneous immunity. Cancer Res., 1993, 73, 728-732.
37. Noonan, F.P.; DeFabo, E.C. Immunosuppression by ultraviolet B radiation, initialization by urocanic acid. Immunology today, 1992, 13(2), 250-254.
38. De Fabo, E.C.; Noonan F.P. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J. Exp. Med., 1983, 158(1), 84-98.
39. Norval, M.; Simpson, T.J.; Ross, J.A. Urocanic acid and immunosuppression. Photochem. Photobiol., 1989, 50(2), 267-275.
40. Kurimoto, I.; Streilein, J.W. Cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J. Immunol., 1992, 148(10), 3072-3078.
41. Greene, M.I.; Sy, M.S.; Kripke, M.; Benacerraf, B. Impairment of antigen-presenting cell function by ultraviolet radiation. Proc. Natl. Acad. Sci. USA, 1979, 76(12), 6591-6595.
42. Reeve, V.E.; Greenoak, G.E.; Canfield, P.J.; Boehm-Wilcox, C.; Gallagher, C.H. Topical urocanic acid enhances UV-induced tumour yield and malignancy in the hairless mouse. Photochem. Photobiol., 1989, 49(4), 459-464.
43. el-Ghorr, AA.; Norval, M.A. Monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in Langerhans cells and delayedhypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. J. Invest. Dermatol., 1995, 105(2), 264-268.
44. Kondo, S.; Sauder, D.N.; McKenzie, R.C.; Hiroshi, F.; Shivji, G.M.; El Ghorr, A.A.; Norval, M. The role of cis-urocanic acid in UVB-induced suppression of contact hypersensitivity. Immunol. Lett., 1995, 48, 181-186.
45. Van Strien, S.A.; Korstange, M.J. Treatment of Comnctact hypersensistivity with urocanic acid. Arch. Dermatol. Res., 1995, 287, 564-566.
46. Norval, M.; El-Ghorr, A.A. Studies to determine the immunomodulating effects of cis-urocanic acid. Methods, 2002, 28(1), 63-70.
47. Kurimoto, I.; Streilein, J.W. Deleterious effects of cis UCA and UVB irradiation on LC and induction of CH are mediated by TNF alpha. J. Invest. Dermatol., 1992, 99, 69s-70s.
48. El Ghorr, A.A.; Norval, M. A monoclonal antibody to cis UCA prevents the ultraviolet induced changes in LC amnd delayed hypersensitivity responses in mice although not preventing dendritic cell accumulation in lymphonode draining the site of irradiation and conctact hypersensityvity responses. J. Invest. Dermatol., 1995, 105, 264-268.
49. Reeve, V.E.; Bosnic, M.; Boehm-Wilcox, C.; Cope, R.B. Pyridoxine supplementation protects mice from suppression of contact hypersensitivity induced by 2-acetyl-4-tetrahydroxybutylimidazole (THI), ultraviolet B radiation (280-320 nm), or cis-urocanic acid. Am. J. Clin. Nutr., 1995, 61(3), 571-576.
50. Beissert, S.; Mohammad, T.; Torri, H.; Lonati, A.; Yan, Z.; Morrison, H.; Granstein, R.D. Regulation of tumor antigen presentation by urocanic acid. J. Immunol., 1997, 159(1), 92-96.
51. Walterscheid, J.P.; Nghiem, D.X.; Kazimi, N.; Nutt, L.K.; McConkey, D.J.; Norval, M.; Ullrich, S.E. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc. Natl. Acad. Sci. USA, 2006, 103(46), 17420-17425.
52. Gilmour, J.W.; Vestay, J.P.; George, S.; Norval, M. The effect of phototherapy and UCA on NK function. J. Invest. Dermatol., 1993, 101, 169-172.
53. Kivisto, K.; Punnonen, K.; Toppari, Jleino L.; Urocanic acid suppreses the activation of human neutrophils in vitro. Inflammation, 1996, 20(5), 451-459.
54. Palaszynski, E.W.; Noonan, F.P.; De Fabo, E.C. Cis-urocanic acid down-regulates the induction of adenosine 3′,5′-cyclic monophosphate by either trans-urocanic acid or histamine in human dermal fibroblasts in vitro. Photochem. Photobiol., 1992, 55(2), 165-171.
55. Jaksic, A.; Finlay-Jones, J.J.; Watson, C.J.; Spencer, L.K.; Santucci, I.; Hart, P.H. Cis-urocanic acid synergizes with histamine for increased PGE2 production by human keratinocytes, link to indomethacin-inhibitable UVB-induced immunosuppression. Photochem. Photobiol., 1995, 61(3), 303-309.
56. Kaneko, K.; Smetana-Just, U.; Matsui, M.; Young, A.R.; John, S.; Norval, M.; Walker, S.L. Cis-Urocanic Acid Initiates Gene Transcription in Primary Human Keratinocytes. J. Immunol. 2008, 181(1), 217-224.
57. Kurimoto, I.; Streilein, J.W. Cis-UCA suppression of conctact hypersensityvity induction is mediated via tumor necrosis factor. J. Immunol., 1992, 148, 3072-3078.
58. Kaneko, K.; Smetana-Just, U.; Matsui, M.; Young, A.R.; John, S.; Norval, M.; Walker, S.L. cis-Urocanic Acid Initiates Gene Transcription in Primary Human Keratinocytes. J. Immunol., 2008, 181(1), 217-224.
59. Moodycliffe, A.M.; Bucana, C.D.; Kripke, M.L.; Norval, M.; Ulrigh, S.E. Differential effect of a monoclonal antibody to cus UCA on the suppression of Delayed type and contact hypersensivity following ultraviolet radiation. J. Immunol., 1996, 157, 2891-2899.
60. Beissert, S.; Rühlemann, D.; Mohammad, T.; Grabbe, S.; El-Ghorr, A.; Norval, M.; Morrison, H.; Granstein, R.D.; Schwarz, T. IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells, implications for photocarcinogenesis. J. Immunol., 2001, 167(11), 6232-6238.
61. Reeve, V.E.; Ley, R.D. Cis Urocanic acid induced suppression of Conctact hypersensitivity in Monodelphis domestica is prevented by Ultraviolet A radiation photoreactivating light. Int. Arch. Allergy Immunol., 1997, 112(3), 257-261.
62. Terrian, D.L.; Kuhl, C.N.; Tessman, I.; Morrison, H. On the roles of cis Urocanic acid in photoimmunosuppression attempted photorepair of urocanic acid DNA cyclobutane adducts with DNA photolyase. Photochem. Photobiol., 1996, 63(6), 898-900.
63. Laihia, J.K.; Uksila, J.; Luhtala, M.; Jansen, C.T. Expression of CD 80 (B7-/BB1) and CB 28 in human whithe blood cells treated with urocanic acid. Arch. Dermatol. Res., 1996, 288 (10), 570-574.
64. De Simone, C.; Masini, C.; Cattaruzza, M.S.; Guerriero, C.; Cerimele, D.; Norval, M. Urocanic acid isomers in patients with non-melanoma skin cancer. Br. J. Dermatol., 2001, 144(4), 858-861.
65. De Gruijl, F.R.; Rebel, H. Early events in UV carcinogenesis - DNA damage, target cells and mutant p53 foci. Photochem. Photobiol., 2004, 84(2), 382-387.
66. Yarosh, D.B. Enhanced DNA repair of cyclobutane pyrimidine dimers changes the biological response to UV-B radiation. Mutat. Res., 2002, 509(1-2), 221-226.
67. Vink, A.A.; Strickland, F.M.; Bucana, C.; Cox, P.A.; Roza, L.; Yarosh, D.B.; Kripke, M.L. Localization of DNA damage and its role in altered antigen presenting cell function in ultraviolet irradiated mice. J. Exp. Med. 1996, 183(4), 1491-1500.
68. Krutmann, J.; Bohnert, E.; Jung. Evidence that DNA damage is a mediate in ultraviolet B radiation-induced inhibition of human gene expression, ultraviolet B radiation effects on intercellular adhesion molecule-1 (ICAM-1) expression. J. Invest. Dermatol., 1994, 102(4), 428-432.
69. Curiel-Lewandrowski, C.; Venna, S.S.; Eller, M.S.; Cruikshank, W.; Dougherty, I.; Cruz, P.D. Jr.; Gilchrest, B.A. Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes. Exp. Dermatol., 2003, 12(2), 145-152.
70. Tommasi, S.; Swiderski, P.M.; Tu, Y.; Kaplan, B.E.; Pfeifer, G.P. Inhibition of transcription factor binding by ultraviolet-induced pyrimidine dimers. Biochemistry, 1996, 35(49), 15693-15703.
71. Kripkie, M.L.; Cox, P.A.; Alas, L.G.; Yarosh, D.B. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV irradiated mice. Proc. Natl. Acad. Sci. USA, 1992, 89, 7516-7520.
72. Vink, A.A.; Moodycliffe, A.M.; Shreedhar, V.; Ullrich, S.E.; Roza, L.; Yarosh, D.B.; Kripke, M.L. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc. Natl. Acad. Sci. USA, 1997, 94(10), 5255-5260.
73. Arad, S.; Konnikov, N.; Goukassian, D.A.; Gilchrest, B.A. T-oligos augment UV-induced protective responses in human skin. FASEB. J., 2006, 20(11), 1895-1897.
74. Vink, A.A.; Strickland, F.M.; Bucana, C.; Cox, P.A.; Roza, L.; Yaroosh, D.B.; Kripkie, M.L. Localization of DNA damage and its role in altered antigen cell presenting finction in ultraviolet irradiated mice. J. Exp. Med., 1996, 183(4), 1491-1500.
75. O'connor, A.; Nishigori, C.; Yarosh, D.; Alas, L; Kibitel, J.; Burley, L.; Cox, P.; Bucana, C.; Ullrich, S.; Kripke, M.L. DNA double strand breacks in epidermal cell cause immune suppression in vivo and cytokine production in vitro. J. Immunol., 1996, 157, 271-278.
76. Kuchel, J.M.; Barnetson, R.S.; Halliday, G.M. Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans. Photochem. Photobiol. Sci., 2005, 4(8), 577-582.
77. Cafardi, J.A.; Elmets, C.A. T4 endonuclease V, Review and application to dermatology. Expert Opin. Biol. Ther., 2008, 8(6), 829-838.
78. Donawho, C.K.; Muller, H.K.; Bucana, C.D.; Kripke, M.L. Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms. J. Immunol., 1996, 157(2), 781-786.
79. Ullrich, S.E. Modulation of immunity by ultraviolet radiation key effect on antigen presentation. J. Invest. Dermatol., 1995, 115, 30s-36s.
80. Wood, G.M.; Qu, M.; Ragg, S.J.; Muller, H.K. Chemical carginoges and antigens induce immunosuppression via Langerhans' cell depletion. Immunology, 1996, 88, 134-139.
81. Bergstresser, P.R.; Toews, G.B.; Streilein, J.W. Langerhans cells, sentinels of skin associated lymphoid tissue. J. Invest. Dermatol., 1980, 75, 73-77.
82. Sugihara, A.; Okamoto, H.; Horio, T. Effects of UVB on fascin expression in dendritic cells and Langerhans cells. J. Dermatol. Sci., 2005, 40(3), 177-185.
83. Grabbe, S.; Steinbrink, K.; Steinert, M.; Luger, T.A.; Schwarz, T. Removal of the majority of epidermal langerhans cells by topical or systemic steroid application enhances the effector phase of murine conctact hypersensitivity. J. Immunol., 1995, 155, 4207.
84. Vink, A.A.; Strickland, F.M.; Bucana, C.; Cox, P.A.; Roza, L.; Yarosh, D.B.; Kripkie, M.L. Localization of DNA damage and its role in altered antigen-presnting cell functionin ultraviolet irradiated mice. J. Exp. Med., 1996, 183, 1491-1500.
85. Richters, C.D.; Reits, E.A.; Van Pelt, A.M.; Hoekstra, M.J.; Van Baare, J.; Du Pont, J.S.; Kamperdijk, E.W. Effect of low dose UVB irradiation on the migratory properties and functional capacities of human skin dendritic cells. Clin. Exp. Immunol., 1996, 104(1), 191-197.
86. El-Ghorr, A.A.; Norval, M.; Lappin, M.B.; Crosby, J.C. The effect of chronic low-dose UVB radiation on Langerhans cells,sunburn cells, urocanic acid isomers, contact hypersensitivity and serum immunoglobulins in mice. Photochem. Photobiol., 1995, 62(2), 326-332.
87. Streilein, J.W.; Taylor, J.R.; Vincek, V.; Kurimoto, I.; Shimizu, T.; Tie, C.; Golomb, C. Immunesurveillance and sunlight-induced skin cancer. Immunol. Today, 1994, 15(4), 174-179.
88. Weiss, J.M.; Renkl, A.C.; Denfeld, R.W.; de Roche, R.; Spitzlei, M.; Schopf, E.; Simon, J.C. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur. J. Immunol., 1995, 25, 2858-2862.
89. Rattis, F.M.; Peguet-Navarro, J.; Courtellemont, P.; Redziniak, G.; Schmitt, D. In vitro effects of ultraviolet B radiation on human Langherhans cell antigen presenting function. Cell Immunol., 1995, 164, 65-72.
90. Weiss, J.M.; Renkl, A.C.; Denfeld, R.W.; de Roche, R.; Spitzei, M.; Schöpf, E.; Simon, J.C. Low dose UVB radiation, perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human langerhans cells. Eur. J. Immunol., 1995, 25, 2858-2860.
91. Bucana, C.D.; Tang, J.M.; Dunner, K.; Strickland, F.M.; Kriopke, M.L. Phenotype and ultrastructural proprieties of antigen presenting cells involved in contact sensitization of normalk and UV - irradiated mice. J. Invest. Dermatol., 1994, 102, 928-933.
92. Richters, C.D.; Reits, E.A.; Van Pelt, A.M.; Hoekstra, M.J.; Van Baare, J.; Du Pont, J.S.; Kamperdijk, E.W. Effect of low dose UVB irradiation on the migratory properties and functional capacities of human skin dendritic cells. Clin. Exp. Immunol., 1996, 104(1), 191-197.
93. Lappin, M.B.; Kimber, I.; Dearman, R.J.; Norval, M. Exposure of UVB sensuitive mice to immunesuppressive doses of UVB in vivo fails to affect the accessory function or the phenotype of draining lymph node dendritic cells. Exp. Dermatol., 1996, 5, 286-294.
94. Kremer, I.B.; Sylva-Streeland R.M.R.; Bos, J.D.; Teunissen, M.B.M. Despite the presence of UVB-induced DNA damage HLA-DR+ cells from ex vivo UVB exposed human skin are able to migrate and show no impaired allostimulatory capacity. J. Invest. Dermatol., 1997, 109, 626-631.
95. Ullrich, S.E Modulation of immunity by ultraviolet radiation, key effect on antigen presentation. J. Invest. Dermatol., 1995, 103, 30s-36s.
96. Grabbe, S.; Bruvers, S.; Beissert, S.; Granstein, R.D. Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Leukoc. Biol., 1994, 55(6), 695-701.
97. Kripke, M.L.; Cox, P.A.; Bucana, C.; Vink, A.A.; Alas, L.; Yarosh, D.B. Role of DNA damage in local suppression of contact hypersensitivity inmice by UV radiation. Exp. Dermatol., 1996, 5(3), 173-180.
98. Beissert, S.; Ullrich, S.E.; Hosoi, J.; Granstein, R.D. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content. J. Leukoc. Biol., 1995, 58(2), 234-240.
99. Simon, J.C.; Tigelaar, R.E.; Bergstresser, P.R.; Edelbaum, D.; Cruz, P.D. Jr. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J. Immunol., 1991, 146(2), 485-491.
100. Dai, R.; Streinelein, J.W. Sensitizing capacity of Langerhans cells obtained from ultraviolet B exposed murine skin. Immunology, 1995, 86, 661-667.
101. Hammenberg, C.; Duraiswamy, N.; Cooper, K.D. Active induction of Unresponsiveness (Tolerance) to DNFB by in vivo Utraviolet exposed epidermal cells is dependent upon infiltrating Class II MHC = CD 11b bright Monocytic/macrophagic cells. J. Immunol., 1994, 153, 4915.
102. Cooper, K.D.; Fox, P.; Neises, G.; Katz, S.I. Effects of ultraviolet radiuation on human epidermal cell alloantigen presentation initial depression of Langherans cells dependent function is followed by the appearance of T6-DR= cells that enhance epidermal alloantigen presentation. J. immunol., 1985, 134, 129.
103. Hammenberg, C.; Duraiswamy, N.; Cooper, K.D. Active induction of Unresponsiveness (Tolerance) to DNFB by in vivo Utraviolet exposed epidermal cells is dependent upon infiltrating Class II MHC = CD 11b bright Monocytic/macrophagic cells. J. Immunol., 1994, 153, 4915.
104. Hammemberg, C.; Duraiswamy, N.; Cooper, K.D. Reversal of immunosuppression inducible through ultraviolet exposed skin by in vivo anti-CD 11b treatment. J. immunol., 1996, 157(12), 5254-5261.
105. Kurimoto, I.; van Rooijen, N.; Diijkstra, C.D.; Streinein, J.W. Role of phagocitic macrophages in induction of conctact hypersensitivity and tolerance by hapten applied to normal and ultraviolet b irradiated skin. Immunology, 1994, 84, 281-287.
106. Kang, K.; Hammemberg, C.; Meunier, L.; Cooper, K.D. CD 11 b= macrophages that infiltrate Human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of Epidermal Il-10 protein. J. Immunol., 1994, 153, 5256.
107. Shreedhar, V.K.; Pride, M.W.; Sun, Y.; Kripke, M.L.; Strickland, F.M. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J. Immunol., 1998, 161, 1327-1333.
108. Schwarz, A.; Maeda, A.; Wild, M.K.; Kernebeck, K.; Gross, N.; Aragane, Y.; Beissert, S.; Vestweber, D.; Schwarz, T. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol., 2004, 172, 1036-1043.
109. Birch, K.E.; Vukmanovic-Stejic, M.; Reed, J.R.; Akbar, A.N.; Rustin, M.H.A. The immunomodulatory effects of regulatory T cells, implications for immune regulation in the skin. British J. Dermatol., 2005, 152(3), 409-417.
110. Schwarz, A.; Maeda, A.; Wild, M. K.; Kernebeck, K.; Gross, N.; Aragane, Y.; Beissert, S.; Vestweber, D.; Schwarz, T. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol., 2004, 172, 1036-1043.
111. Beissert, S.; Schwarz, A.; Schwarz, T. Regulatory T cells. J. Invest. Dermatol., 2006, 126(1), 15-24.
112. Schwarz, A.; Maeda, A.; Wild, M.K.; Kernebeck, K.; Gross, N.; Aragane, Y.; Beissert, S.; Vestweber, D.; Schwarz, T. Ultraviolet radiation- induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol., 2004, 172, 1036-1043.
113. Loser, K.; Apelt, J.; Voskort, M.; Mohaupt, M.; Balkow, S.; Schwarz, T.; Grabbe, S.; Beissert, S. IL-10 controls ultraviolet-induced carcinogenesis in mice. J. Immunol., 2007, 179, 365-371.
114. Ullrich, S.E. Does exposure to UV radiation induce to a shift to a Th 2 like immunereaction? Photochem. Photobiol., 1996, 64(2), 254-258.
115. Shreedhar, V.; Giese, T.; Sung, V. W.; Ullrich, S. E. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol., 1998, 160, 3783-3789.
116. Araneo, B.; Dowell, T.; Moon, H.B.; Daynes, R.A. Regulation of murine lymphocytes prooduction in vivo. UV radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an Il-1 dependent mechanism. J. Immunol., 1989, 143, 1737-1744.
117. Ullrich, S.E. Mechanism involved in the systemic suppression of antigen -presenting cell function by UV radiation, keratinocyte-derived IL-10 modulates antigen presenting cell function of splenic adherent cells. J. Immunol., 1994, 152, 3410-3416.
118. Kim, J.; Modlin, R. L.; Moy, R. L.; Dubinett, S. M.; McHugh, T.; Nickoloff, B. J.; Uyemura, K. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol., 1995, 155, 2240-2245.
119. Kruger-Krasagakes, S.; Krasagakis, K.; Garbe, C.; Schmitt, E.; Huls, C.; Blankenstein, T.; Diamantstein, T. Expression of interleukin 10 in human melanoma. Br. J. Cancer, 1994, 70, 1182-1185.
120. Nishigori, C.; Yarosh, D.B.; Ullrich, S.E.; Vink, A.A.; Bucana, C.D.; Roza, L.; Kripke, M.L. Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc. Natl. Acad. Sci. USA, 1996, 93(19), 10354-10359.
121. Niizeki, H.; Streilein, J.W. Hapten-specific tolererance induced by acute low dose Ultraviolet B radiation of skin is mediated via Inteleukin 10. J. Invest. Dermatol., 1997, 109, 25-30.
122. Beissert, S.; Ullrich, S.E.; Hosoi, J.; Granstein, R.D. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content. J. Leukoc. Biol., 1995, 58(2), 234-240.
123. Rivas, J.M.; Ullrich, S.E. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J. Leukoc. Biol., 1994, 56(6), 769-775.
124. Niizeki, H.; Streilein, J.W. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol., 1997, 109(1), 25-30.
125. Enk, C.D.; Sredni, D.; Blauvelt, A.; Katz, S.I. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J. Immunol., 1995, 154(9), 4851-4856.
126. Teunissen, M.B.; Koomen, C.W.; Jansen, J.; de Waal Malefyt, R.; Schmitt, E.; Van den Wijngaard, R.M.; Das, P.K.; Bos, J.D. In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL-10 mRNA and protein. Clin. Exp. Immunol., 1997, 107(1), 213-223.
127. Kang, K.; Hammemberg, C.; Meunier, L.; Cooper, K.D. CD 11b+ macrophages that infiltrate the human epidermis after in vivo ulktraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10. J. Immunol., 1994, 153, 5256-5264.
128. El-Ghorr, A.A.; Norval, M. The role of Interleukin 4 in ultraviolet B light-induced immunosuppression. Immunology, 1997, 92, 26-32.
129. Lee, H.S.; Kooshesh, F.; Sauder, D.N.; Kondo S. Modulation of TGF-beta 1 production from human keratinocytes by UVB. Exp. Dermatol., 1997, 6(2), 105-110.
130. Schmitt, D.A.; Owen-Schaub, L.; Ullirch, S.E. Effect of IL-12 on Immune suppression and Suppressor cell induction by Ultraviolet radiation. J. Immunol., 1995, 154, 5114-5120.
131. Schwartz, A.; Grabbe, S.; Aragane, Y.; Sandkuhl, K.; Riemann, H.; Luger, T.A.; Kubin, M.; Tringheri, G.; Shwartz, T. Interleukin 12 prevents ultraviolet B induced local immunosuppression and overcomes UVB inuced tolerance. J. Invest. Dermatol., 1996, 106, 1187-1191.
132. Riemann, H.; Schwarz, A.; Grabbe, S.; Aragane, Y.; Luger, T.A.; Wysocka, M.; Kubin, M.; Trincheri, G.; Schwartz, T. Neutralization of IL-12 in vivo prevents inductionoof conctact hypersensitivity and induces hapten specific tolerance. J. immunol., 1996 1586, 1799-1803.
133. Kremer, I.B.; Hilkens, C.M.U.; Sylva-Steenland, R.M.R.; Koomen, C.W.; Kapsenberg, M.L.; Bos, J.D.; Teunissen, M.B.M. Reduced IL-12 production by monocytes upon ultraviolet B irradiation selectively limits activation of T helper-1 cells. J. immunol., 1996, 157, 1913-1918.
134. Lamont, A.G.; Adorini, L. IL-12, a key cytokine in immune regulation. Immunol. Today, 1996, 17(5), 214-217.
135. Schwarz, A.; Maeda, A.; Kernebeck, K.; van Steeg, H.; Beissert, S.; Schwarz, T. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J. Exp. Med., 2005, 201(2), 173-179.
136. Streilein, J.W. Sunlight and skin associated lymphoid tissue (SALT), if UVB is the trigger and TNF-α its mediator, what is the message? J. Invest. Dermatol., 1993, 100, 47s-52s.
137. Grabbe, S.; Bruvers, S.; Lindgren, A.M.; Hosoi, J.; Tan, K.C.; Granstein, R.D. Tumor antigen presentation by epidermal antigen presenting cells in mouse, modulation by GM-CSF, TNF-aplha and UVB. J. Leukoc. Biol., 1992, 52, 209-217.
138. Moodycliffe, A.M.; Kiimber, I.; Norval, M. Role of tumor necrosis factor-α in ultraviolet B light-induced dendritic cell migration and suppression of conctact hypersensitivity. Immunology, 1994, 81, 79-84.
139. Nakamura, T.; Pinnel, S.R.; Darr, D.; Kurimoto, I.; Itami, S.; Yoshikawa, K.; Streilein, J.W. VitaminC abrogats the deleterious effects of UVB radiation on cutaneous immunity by a mechanism that does not depend on TNF-α. J. Invest. Dermatol., 1997, 109, 20-27.
140. Shimizum, T.; Streilein, J.W. Evidence that ultraviolet B radiation induce tolerance and impairs induction of conctact hyprsensitivity by different mechanisms. Immunology, 1994, 82(1), 140-148.
141. Shimizu, T.; Streilein, J.W. Local and systemic consequence acute low dose ultraviolet B radiation are mediated by different immune regulatory mechanism. Eur. J. Immunol., 1994, 24, 1765-1770.
142. Kondo, S.; Wang, B.; Fujisawa, H.; Shivji, G.M.; Echtenache, B.; Mak, T.W.; Sauder, D.N. Effect of targeted mutation in TNF receptor p55 on conctact Hypoersensitivity and ultr\aviolet B induced Immunosuppression. J. Immunol., 1995, 155, 3801-3805.
143. Amerio, P.; Toto, P.; Feliciani, C.; Suzuki, H.; Shivji, G.; Wang, B.; Sauder, D.N. Rethinking the role of tumour necrosis factoralpha in ultraviolet (UV) B-induced immunosuppression, altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice. Br. J. Dermatol., 2001, 144, 952-957.
144. Schwarz, T. Photoimmunosuppression. Photodermatol. Photoimmunol. Photomed., 2002, 18(3), 141-145.
145. Hayashi, Y.; Aurelian, L. Immunity to herpes simplex virus type viral antigen-presenting capacity of epidermal cells and its impairment by ultraviolet irradiation. J. Immunol.; 1986,136, 1087-1092.
146. Howie, S.; Norval, M.; Maingay, J. Exposure to low-dose ultraviolet radiation suppresses delayed-type hypersensitivity to herpes simplex virus in mice. J. Invest. Dermatol., 1986, 86(2), 125-128.
147. El-Ghorr, A.A.; Norval, M. The effect of UV-B irradiation on primary and secondary HSV-1 infections in interleukin-4 knockout mice. Arch. Dermatol. Res., 1999, 291(7-8), 459-465.
148. Fresno, M.; Kopf, M.; Rivas, L. Cytokines and infectious diseases. Immunol. Today, 1997, 18(2), 56-58.
149. zur Hausen, H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta, 1996, 1288, F55-F78.
150. Fourtanier, A.; Moyal, D.; Maccario, J.; Compan, D.; Wolf, P.; Quehenberger, F.; Cooper, K.; Baron, E.; Halliday, G.; Poon, T.; Seed, P.; Walker, S.L.; Young, A.R. Measurement of sunscreen immune protection factors in humans, a consensus paper. J. Invest. Dermatol., 2005, 125(3), 403-409.
151. Baliga, M.S.; Katiyar, S.K. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci., 2006, 5(2), 243-253.